Powder: -20°C for 3 years
In solvent: -80°C for 2 years
BIM-23190 aceate, a somatostatin analog, a selective agonist of SSTR2 and SSTR5. BIM-23190 can be used in cancer and acromegaly studies.
Description | BIM-23190 aceate, a somatostatin analog, a selective agonist of SSTR2 and SSTR5. BIM-23190 can be used in cancer and acromegaly studies. |
Targets&IC50 | SST5:11.1 nM(Kd), SST2:0.34 nM(Kd) |
In vitro | BIM-23190 tends to mildly stimulate PRL secretion. The Ki values are 0.34 nM and 11.1 nM for SSTR2 and SSTR5, respectively[3]. |
In vivo | In male athymic nude (nu/nu) mice, BIM-23190 (50 μg/mouse, twice a day) significantly reduced the tumor growth rate and exhibited significant anti-tumor (C6 glioma) activity[1]. |
Molecular Weight | 1262.5 |
Formula | C59H83N13O14S2 |
Powder: -20°C for 3 years
In solvent: -80°C for 2 years
( < 1 mg/ml refers to the product slightly soluble or insoluble )
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
BIM-23190 aceate BIM23190 aceate BIM 23190 aceate Inhibitor inhibitor inhibit